Micromedex IV Compatibility: what it costs, how to get access, and the alternatives

The short answer: Micromedex IV Compatibility is Merative's parenteral compatibility tool, powered by Trissel's 2 Clinical Pharmaceutics Database. Merative publishes no price for it. There is no dollar figure and no self-serve checkout on the product page, so it is sold as an institutional subscription by quote. The detail worth knowing before you renew anything: Wolters Kluwer licenses the same Trissel's database into UpToDate Lexidrug, so plenty of health systems are paying two vendors for one body of evidence.

Compatibility questions are unforgiving in a way that most drug lookups are not. A nurse standing at a pump with two running lines needs a yes, a no, or an honest "this was never tested", and needs it in seconds. That urgency is why hospitals buy these databases, and it is also why the purchase rarely gets audited once it is in place.

What Micromedex IV Compatibility actually contains

Merative describes the product plainly on its own page. It is powered by Trissel's IV compatibility tool, which is to say Trissel's 2 Clinical Pharmaceutics Database, and it is kept current through the Micromedex editorial process. The vendor lists more than 80,800 compatibility results covering over 1,400 parenteral drugs and solutions, chemotherapy agents included, built from more than 4,600 peer-reviewed articles and other sources.

It reports both drug-solution and drug-drug results, which matters more than it sounds. Whether a medication is stable in the bag it is hanging in and whether it can share a Y-port with something else are different questions with different answers, and a tool that blurs them is not much use at the bedside.

The Trissel's name carries real lineage. It comes from the Handbook on Injectable Drugs, which ASHP has published since 1977 and which a generation of pharmacists still calls "Trissel's" after its original author, Lawrence A. Trissel. When a vendor says its compatibility data is powered by Trissel's, that is the body of work being referenced.

How much does Micromedex IV Compatibility cost?

Merative publishes nothing. We checked the product page again in August 2026 and there is no price, no tier list and no checkout, only a route to contact sales. That is normal for this category rather than evasive: the product is sold to hospital pharmacy and procurement, and institutional pricing is negotiated one organization at a time.

The practical problem for a buyer is the absence of an anchor. You cannot tell whether your quote is good without a public number to compare it against, and in this market there is exactly one.

King Guide puts its whole rate card on the web: $475 for a single user, $599 for an educational institution, $760 for a site license under 250 beds, $1,100 from 251 to 1,500 beds and $2,100 above that. Those figures were verified at the vendor's own store in August 2026. Whatever you think of the product, that rate card is the only public number anyone in a Micromedex negotiation can point at, and it is worth having in front of you.

The pattern holds across clinical reference software generally. Products bought by a procurement department publish nothing; products bought by one clinician with a credit card show a price. We measured the same asymmetry in detail in our Micromedex cost breakdown and across the disease references in the UpToDate subscription cost guide.

Is Micromedex IV Compatibility free?

No, though it can look that way. The unified Micromedex app is free to download on the US App Store, and free to download is not free to use. The compatibility content behind it needs a subscription, which almost always arrives through a hospital, a health system or a university library.

So if you can already open it without having paid anything, someone in your organization is paying for it. That is worth confirming before you go looking for a personal subscription, because personal purchases of access people already hold are the most common waste in this category.

Is there still a separate IV Compatibility app?

No. Merative consolidated its mobile products into a single Micromedex app. A search of the US App Store in August 2026 returns one free Micromedex app from Merative US L.P., with no standalone IV Compatibility listing beside it. Subscribers reach compatibility content inside the unified app rather than through a separate download.

If your unit still has the old standalone app pinned to a shared device, that is worth checking. An unsupported app that silently stops updating is a genuine safety problem when the content is compatibility data.

The duplicate licensing trap

Here is the part that costs real money. Wolters Kluwer sells Trissel's IV Compatibility as a module inside UpToDate Lexidrug. Merative sells Micromedex IV Compatibility. Two vendors, two contracts, two interfaces, and underneath them the same Trissel's 2 Clinical Pharmaceutics Database.

Health systems end up holding both for ordinary reasons rather than careless ones. Pharmacy licenses Micromedex, the medical staff licenses UpToDate and its drug module comes along with it, and the two contracts renew on different dates through different budget lines. Nobody in either sales conversation has a reason to mention the overlap. This is the same duplicate-subscription problem that shows up whenever software spend is spread across separate departmental budgets, and it is only ever caught by someone deliberately comparing the two contracts side by side.

The fix is a single question to your pharmacy informatics or library team: do we hold Trissel's, King Guide, or both, and through how many vendors? If the answer is Trissel's twice, you have a negotiating position at the next renewal. We walk through how those conversations actually go in the institutional license guide, and the two underlying drug databases are compared directly in Lexicomp vs Micromedex.

What to use instead

King Guide to Parenteral Admixtures is the meaningful alternative, because it is independently compiled rather than another window onto Trissel's. King Guide Publications lists 610 injectable drug monographs and more than 3,403 peer-reviewed references, updated quarterly, and applies a deliberately narrow editorial rule: only material published in peer-reviewed and refereed journals, or supplied by the manufacturer. In 2026 it is in its 55th year.

That independence is the actual argument for it. When a pair falls outside the tested range in one source, a second source compiled from a different reading of the literature is genuinely useful, which is why plenty of hospital pharmacies hold both rather than treating it as an either-or.

ASHP Injectable Drug Information remains the other established option and is often reached through Stat!Ref in hospital libraries. For neonatal and pediatric questions, ASHP's Pediatric Injectable Drugs, known almost universally as the Teddy Bear Book, is the volume to reach for instead of an adult-focused database.

King Guide also sells printed Y-site wall charts covering a smaller drug list and the common infusion fluids. For a critical care unit that mostly needs an at-a-glance answer for a familiar set of drips, a chart on the wall can be a better purchase than a database license nobody opens. We compare the full set of options in the IV compatibility checker buyer's guide.

Why two tools disagree about the same pair

Compatibility is not a fixed property of two molecules. Every result comes from a specific study run at a specific concentration, in a specific container, in a specific fluid, at a specific temperature, for a specific duration. Change any of those and the finding can change.

So when Trissel's and King Guide report differently, they are usually reporting different experiments rather than contradicting one another. A pair tested at one concentration may never have been tested at yours, and "not tested" is not the same as "incompatible", though it calls for the same caution. The better tools show the study conditions behind a result instead of a bare verdict, and that is a reasonable thing to demand in a demo before you sign.

Where compatibility ends and interaction checking begins

These two get spoken about together and are answered by different products. Compatibility is a pharmaceutics question about what happens in the line or the bag: precipitation, particulates, degradation. Interaction checking is a pharmacology question about what happens in the patient after both drugs are on board.

We are direct about which of those we do. Prescriber.io checks interactions, flags contraindications and surfaces renal and hepatic dosing with cited sources, and it does not license Trissel's or King Guide, so it will not answer a Y-site question. If that is your problem, buy one of the tools above. If the question is whether two medications belong on the same chart at all, that is what our drug interaction checker was built for, and we publish every per-seat rate rather than routing you to a quote.